Suchergebnisse - (Person:"Adhikari, Nilanjan")

PubPharm (8)

1

Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning

enthalten in: Journal of biomolecular structure & dynamics | 2021

von Amin, S. | Adhikari, N. | Jha, T.

2

HDAC6 as privileged target in drug discovery : A perspective

enthalten in: Pharmacological research | 2021

von Pulya, S. | Amin, S. | Adhikari, N. | +3

3

Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer : A minireview

enthalten in: European journal of medicinal chemistry | 2020

von Mondal, S. | Adhikari, N. | Banerjee, S. | +2

ErratumIn: Eur J Med Chem. 2020 Nov 1;205:112642. - PMID 32750565

4

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents : A review

enthalten in: European journal of medicinal chemistry | 2020

von Sarkar, R. | Banerjee, S. | Amin, S. | +2

5

Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2019

von Trivedi, P. | Adhikari, N. | Amin, S. | +4

6

Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms : An overview

enthalten in: European journal of medicinal chemistry | 2019

von Banerjee, S. | Adhikari, N. | Amin, S. | +1

7

HDAC3 is a potential validated target for cancer : An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches

enthalten in: European journal of medicinal chemistry | 2018

von Adhikari, N. | Amin, S. | Trivedi, P. | +2

8

Structure-activity relationships of HDAC8 inhibitors : Non-hydroxamates as anticancer agents

enthalten in: Pharmacological research | 2018

von Amin, S. | Adhikari, N. | Jha, T.

1
[1]